AngioDynamics, Inc. · NASDAQ (us_market)
Healthcare · Medical Instruments & Supplies · United States
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, diagnostic and interventional guidewires, and coaxial micro-introducer kits for use in peripheral diagnostic and interventional procedures. In addition, the company provides abscession drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-access kits offer interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.
| Event Period | Drawdown | Buy Point (Bottom) | Sell Point (Peak) | ticker.setupCols.buyScore | ticker.setupCols.sellScore | Max Return | Algo Return |
|---|---|---|---|---|---|---|---|
DROP2025-12-22$13.64 RISE2026-04-07$9.70 PEAK2026-05-21$11.96 150d | -28.9% 106d | Missed | Missed | — | — | +23.3% 44d | Missed |
DROP2025-12-22$13.64 RISE2026-01-09$9.86 PEAK2026-04-01$11.94 100d | -27.7% 18d | Missed | Missed | — | — | +21.1% 82d | Missed |
DROP2025-06-10$11.14 RISE2025-08-06$8.40 PEAK2025-10-24$12.34 136d | -24.6% 57d | Missed | Missed | — | — | +46.9% 79d | Missed |
DROP2025-01-08$12.94 RISE2025-05-06$8.63 PEAK2025-06-10$11.14 153d | -33.3% 118d | Missed | Missed | — | — | +29.1% 35d | Missed |
DROP2025-01-08$12.94 RISE2025-03-10$8.37 PEAK2025-06-04$10.96 147d | -35.3% 61d | Missed | Missed | — | — | +30.9% 86d | Missed |
DROP2024-07-31$7.84 RISE2024-10-08$5.88 PEAK2024-12-16$9.33 138d | -25.0% 69d | Missed | Missed | — | — | +58.7% 69d | Missed |
DROP2024-04-05$7.03 RISE2024-07-08$5.51 PEAK2024-07-31$7.84 117d | -21.6% 94d | Missed | Missed | — | — | +42.3% 23d | Missed |
DROP2023-12-27$8.04 RISE2024-03-25$5.27 PEAK2024-04-05$7.03 100d | -34.5% 89d | Missed | Missed | — | — | +33.4% 11d | Missed |
DROP2023-12-27$8.04 RISE2024-01-18$5.84 PEAK2024-04-05$7.03 100d | -27.4% 22d | Missed | Missed | — | — | +20.4% 78d | Missed |
DROP2023-07-11$9.94 RISE2023-11-09$6.17 PEAK2023-12-27$8.04 169d | -37.9% 121d | Missed | Missed | — | — | +30.3% 48d | Missed |
DROP2023-01-05$15.48 RISE2023-04-27$8.29 PEAK2023-06-20$11.16 166d | -46.4% 112d | Missed | Missed | — | — | +34.6% 54d | Missed |
DROP2023-01-05$15.48 RISE2023-04-26$8.29 PEAK2023-06-20$11.16 166d | -46.4% 111d | Missed | Missed | — | — | +34.6% 55d | Missed |
DROP2022-08-11$24.30 RISE2022-12-05$12.06 PEAK2023-01-05$15.48 147d | -50.4% 116d | Missed | Missed | — | — | +28.4% 31d | Missed |
DROP2022-08-11$24.30 RISE2022-10-24$13.07 PEAK2023-01-05$15.48 147d | -46.2% 74d | Missed | Missed | — | — | +18.4% 73d | Missed |
DROP2022-03-02$24.50 RISE2022-06-14$17.83 PEAK2022-08-11$24.30 162d | -27.2% 104d | Missed | Missed | — | — | +36.3% 58d | Missed |
1–15 / 21 1 / 2 | |||||||
The mean of analysts' price targets for AngioDynamics (ANGO) points to a 50.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
ANGO gains momentum as NanoKnife adoption, strong Med Tech growth and positive clinical trends support its long-term outlook.
Pivotal U.S. Data Show Sustained Oncologic Control and Safety Profile at 24 monthsResults Presented at AUA 2026AngioDynamics, Inc. (NASDAQ:ANGO), a medical technology company focused on restoring healthy blood flow in
Pivotal U.S. Data Show Sustained Oncologic Control and Safety Profile at 24 monthsResults Presented at AUA 2026...
The mean of analysts' price targets for AngioDynamics (ANGO) points to a 64.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
-SEC Filing
The average of price targets set by Wall Street analysts indicates a potential upside of 65.8% in AngioDynamics (ANGO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
AngioDynamics (NASDAQ:ANGO) CEO Jim Clemmer used a presentation at Needham & Company’s 25th Annual Needham Healthcare Conference to outline the company’s multi-year transformation, highlight growth drivers in its MedTech segment, and discuss clinical and commercial plans for its three primary pl
The heavy selling pressure might have exhausted for AngioDynamics (ANGO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
AngioDynamics (ANGO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
AngioDynamics tops estimates as revenue rises and losses narrow, driven by Med Tech demand, even as gross margin slips.
Canaccord Genuity analyst John Young maintains AngioDynamics (NASDAQ:ANGO) with a Buy and lowers the price target from $18 to $16.
AngioDynamics' Med Tech business continues to show robust growth, but margins and legacy Medical Devices drag on valuation. Read why I rate ANGO stock a Buy.
AngioDynamics Inc (ANGO) reports robust revenue increases across key segments, but faces ongoing financial pressures and margin declines.
Moby summary of AngioDynamics, Inc.'s Q3 2026 earnings call
AngioDynamics Q3 2026 results beat EPS estimates and raised full-year guidance, driven by strong 19% growth in its Med Tech portfolio.
AngioDynamics, Inc. (ANGO) Q3 2026 Earnings Call April 2, 2026 8:00 AM EDTCompany ParticipantsJames Clemmer - CEO, President & DirectorStephen...
2026-04-02. The following slide deck was published by AngioDynamics, Inc.
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| ANGO | +2.87% | +1.06% | -10.59% | +12.55% |
| XLV | +2.97% | -5.72% | -3.44% | +12.69% |
| Alpha (stock − sector) | -0.10% | +6.77% | -7.15% | -0.14% |
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| Citadel | multi-strat | 3.18M | $36.18M | 0.05% | Added+12.6% | 2026-03-31 |
| StateStreet | passive | 1.33M | $15.17M | 0.00% | Added+4.8% | 2026-03-31 |
| RenTech | quant | 803.3K | $9.13M | 0.01% | Trimmed-4.7% | 2026-03-31 |
| TwoSigma | quant | 230.5K | $2.62M | 0.00% | Trimmed-24.4% | 2026-03-31 |
| FidelityFMR | fundamental | 94.7K | $1.08M | 0.00% | Trimmed-26.2% | 2026-03-31 |
| TRowePrice | fundamental | 48.7K | $554 | 0.00% | Added+10.0% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-07-15upcoming | -0.09 | — | — |
| 2026-04-02 | -0.11 | 0.02 | +118.18% |
| 2026-01-06 | -0.10 | — | +100.00% |
| 2025-10-02 | -0.25 | -0.26 | -5.40% |
| 2025-07-15 | -0.12 | -0.03 | +75.00% |
| 2025-04-02 | -0.13 | 0.03 | +123.08% |
| 2025-01-08 | -0.11 | -0.04 | +63.64% |
| 2024-10-03 | -0.15 | -0.11 | +25.00% |
| 2024-07-16 | -0.17 | -0.06 | +64.00% |
| 2024-04-04 | -0.15 | -0.16 | -3.23% |
| 2024-01-05 | -0.07 | -0.05 | +33.33% |
| 2023-10-04 | -0.13 | -0.12 | +7.69% |
| 2023-07-12 | 0.02 | 0.02 | -11.11% |
| 2023-03-30 | -0.01 | -0.03 | -300.00% |
| 2023-01-05 | -0.01 | 0.01 | +200.00% |
| 2022-10-06 | -0.02 | -0.06 | -166.67% |